Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors

Group 1 - Oscar Health, Inc. (OSCR) experienced a decline of 4.62% to $20.45, underperforming the S&P 500's daily loss of 0.11% [1] - Over the past month, shares of Oscar Health have increased by 50.35%, while the Finance sector and S&P 500 gained 3.03% and 5.17% respectively [1] Group 2 - The upcoming earnings report for Oscar Health is expected to show an EPS of $0.34, reflecting a 70% increase year-over-year, with projected revenue of $2.86 billion, up 28.96% from the previous year [2] - Full-year estimates predict earnings of $0.61 per share and revenue of $11.21 billion, indicating year-over-year growth of 510% and 22.12% respectively [3] Group 3 - Recent modifications to analyst estimates for Oscar Health suggest a positive outlook, as these revisions often indicate short-term business trends [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Oscar Health at 3 (Hold), with a consensus EPS projection that has decreased by 11.11% in the past 30 days [5][6] Group 4 - Oscar Health has a Forward P/E ratio of 34.96, significantly higher than the industry average of 10.13, indicating that the company is trading at a premium [7] - The Insurance - Multi line industry, part of the Finance sector, holds a Zacks Industry Rank of 95, placing it in the top 39% of over 250 industries [7][8]